RWE Demystified
There are lots of buzzwords floating around and especially with the FDA having a bigger focus on RWE it’s top of mind for many stakeholders. Many teams in the different pharma organizations concentrate on this type of evidence.
There are lots of buzzwords floating around and especially with the FDA having a bigger focus on RWE it’s top of mind for many stakeholders. Many teams in the different pharma organizations concentrate on this type of evidence.
In today’s episode, Liz Cole and I will dive deep into a topic called content marketing. It’s kind of meta, since this podcast itself originates on these ideas. Does this sound frightening or disturbing? It shouldn’t.
In today’s episode, Karim and I cover cutting edge examples of how data science and statistical sciences are intersecting. Learn from this episode why different approaches matter when looking at clinical development data.
In today’s episode, we will talk about the data ops manifesto which addresses such problems. There are actually a couple of such manifestos out there such as the agile manifesto or the dev ops manifesto. These sound similar to Demings 14 principles outlined in his “out of the crisis” publication.
Today, we’re reflecting on the 5 behaviors Olaf mentioned and add a great 6th one, which is very relevant as well.
Today’s interview is surely beneficial to every statistician – both early and later in their career as Andy Grieve shares from his wealth of experience across the industry and academia working in senior roles.
Only specialized statisticians discussed indirect comparisons in the past but over the years the topic developed into something, every statistician should know about.
During this episode, we review some highlights from this year. It’ll help you remember a couple of lessons learned or inspire you to listen to some episodes (again).
This final episode aims to prepare you for the interview process. You’ll learn what to expect at an interview or assessment center, and hear experiences from both sides of the table. An interesting listen that you won’t want to miss!
In today’s episode, Benjamin and I discuss some backgrounds for baseline testing in randomized studies.